18 -2 (88) 2026 - Rabbimova G.T. - CLINICAL AND EPIDEMIOLOGICAL PROFILE OF RECURRENT VULVOVAGINAL INFECTIONS IN WOMEN OF REPRODUCTIVE AGE

CLINICAL AND EPIDEMIOLOGICAL PROFILE OF RECURRENT VULVOVAGINAL INFECTIONS IN WOMEN OF REPRODUCTIVE AGE

Rabbimova G.T. - Samarkand State Medical University

Resume

Recurrent vulvovaginal infections are associated with frequent relapses and impaired quality of life. Aim: to describe clinical phenotypes (bacterial vaginosis, vulvovaginal candidiasis, aerobic vaginitis, and mixed forms), identify risk factors for frequent relapses, and assess patient-reported symptoms. Methods: an observational study included 40 reproductive-age women with ≥3 symptomatic episodes in the last 12 months. Diagnosis relied on clinical examination, vaginal pH, and microscopy (Nugent score for bacterial vaginosis; Donders’ criteria for aerobic vaginitis) plus microscopy/culture for candidiasis. Symptom burden was measured using the 21-item Vulvovaginal Symptoms Questionnaire and a visual analog scale. Results: phenotype distribution, associated factors, and quality-of-life indicators are reported. Conclusion: systematic assessment of mixed forms and aerobic vaginitis is essential in recurrent disease to improve diagnosis and guide therapy.

Keywords: recurrent vulvovaginal infections; bacterial vaginosis; vulvovaginal candidiasis; aerobic vaginitis; mixed vaginitis; quality of life.

First page

89

Last page

93

For citation:Rabbimova G.T. - CLINICAL AND EPIDEMIOLOGICAL PROFILE OF RECURRENT VULVOVAGINAL INFECTIONS IN WOMEN OF REPRODUCTIVE AGE//New Day in Medicine 2(88)2026 89-93 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

1. Аполихина И.А., Казакова С.Н., Яроцкая Е.Л., Горбунова Е.А., Бычкова А.Е. Языковая, культурная адаптация и валидация опросника вульвовагинальных симптомов среди пациенток с вульвовагинальной атрофией. // Акушерство и гинекология. 2023;10:177–182. doi:10.18565/aig.2023.228.
2. British Columbia Centre for Disease Control (BCCDC) Clinical Prevention Services. Reproductive Health Decision Support Tool – Certified Practice: Bacterial Vaginosis. May 2025 (дата обращения: 29.12.2025).
3. Centers for Disease Control and Prevention. Bacterial Vaginosis. Sexually Transmitted Infections Treatment Guidelines. 2021 (дата обращения: 29.12.2025).
4. Dong M., Wang C., Li H., et al. Aerobic vaginitis diagnosis criteria combining Gram stain with clinical features: an establishment and prospective validation study. Diagnostics (Basel). 2022;12(1):185. doi:10.3390/diagnostics12010185.
5. Erekson E.A., Li F.Y., Martin D.K., Fried T.R. The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. // Menopause. 2013; 20 (9): 973–979. doi:10.1097/GME.0b013e318282600b.
6. Muzny C.A., Balkus J., Mitchell C., et al. Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. // Clin Infect Dis. 2022;74(Suppl_2):S144–S151. doi:10.1093/cid/ciac021.
7. Qi W., Li H., Wang C., et al. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis. Front Cell Infect Microbiol. 2021;11:759795. doi:10.3389/fcimb.2021.759795.
8. Workowski K.A., Bachmann L.H., Chan P.A., et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. doi:10.15585/mmwr.rr7004a1.

   file

   download